Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M102158-1g | 1g | In stock | $64.90 | |
M102158-5g | 5g | In stock | $103.90 | |
M102158-25g | 25g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $468.90 | |
M102158-100g | 100g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,684.90 |
Imidazole antifungal agent
Synonyms | Antifungal Body | Miconasil Nitrate | MICONAZOLE NITRATE [MART.] | Freds | Antifungal Cream | Daktarin talc | MICONAZOLE NITRATE (EP MONOGRAPH) | VW4H1CYW1K | Albistat | MICONAZOLE NITRATE (EMA EPAR VETERINARY) | Miconazole nitrate [USAN:USP:JAN] | M-zole |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Imidazole antifungal agent. Inhibits fungal membrane ergosterol biosynthesis. Increases reactive oxygen species production. |
Shipped In | Normal |
Action Type | INHIBITOR |
Mechanism of action | Cytochrome P450 51 inhibitor |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488184174 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488184174 |
IUPAC Name | 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid |
INCHI | InChI=1S/C18H14Cl4N2O.HNO3/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22;2-1(3)4/h1-8,11,18H,9-10H2;(H,2,3,4) |
InChi Key | MCCACAIVAXEFAL-UHFFFAOYSA-N |
Canonical SMILES | C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-] |
Isomeric SMILES | C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-] |
WGK Germany | 3 |
RTECS | NI4771000 |
PubChem CID | 68553 |
Molecular Weight | 479.14 |
Reaxy-Rn | 4225531 |
Enter Lot Number to search for COA:
Solubility | Slightly soluble in water; Soluble in Methanol |
---|---|
Melt Point(°C) | 184 °C(dec.) |
Pictogram(s) | GHS09, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H319:Causes serious eye irritation H302:Harmful if swallowed H317:May cause an allergic skin reaction H410:Very toxic to aquatic life with long lasting effects |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P391:Collect spillage. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. |
WGK Germany | 3 |
RTECS | NI4771000 |
Reaxy-Rn | 4225531 |
Merck Index | 6178 |
1. Aggarwal A, Parai MK, Shetty N, Wallis D, Woolhiser L, Hastings C, Dutta NK, Galaviz S, Dhakal RC, Shrestha R et al.. (2017) Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.. Cell, 170 (2): (249-259.e25). [PMID:28669536] |
2. Wettmarshausen J et al.. (2018) MICU1 Confers Protection from MCU-Dependent Manganese Toxicity.. Cell Rep, 25 (6): (1425-1435.e7). [PMID:30403999] |
3. Francis X Cunningham,Hansel Lee,Elisabeth Gantt. (2006-11-07) Carotenoid biosynthesis in the primitive red alga Cyanidioschyzon merolae.. Eukaryotic cell, 6 ((3)): (533-545). [PMID:17085635] |
4. Michele Tonelli,Vito Boido,Caterina Canu,Anna Sparatore,Fabio Sparatore,Maria Silvia Paneni,Maurizio Fermeglia,Sabrina Pricl,Paolo La Colla,Laura Casula,Cristina Ibba,David Collu,Roberta Loddo. (2008-09-02) Antimicrobial and cytotoxic arylazoenamines. Part III: antiviral activity of selected classes of arylazoenamines.. Bioorganic & medicinal chemistry, 16 ((18)): (8447-8465). [PMID:18760610] |
5. Margot Brickelmaier,Alexey Lugovskoy,Ramya Kartikeyan,Marta M Reviriego-Mendoza,Norm Allaire,Kenneth Simon,Richard J Frisque,Leonid Gorelik. (2009-03-05) Identification and characterization of mefloquine efficacy against JC virus in vitro.. Antimicrobial agents and chemotherapy, 53 ((5)): (1840-1849). [PMID:19258267] |
6. Yuan Cao,Ji-Jun Chen,Ning-Hua Tan,Lukas Oberer,Trixie Wagner,Yong-Ping Wu,Guang-Zhi Zeng,He Yan,Qiang Wang. (2010-03-26) Antimicrobial selaginellin derivatives from Selaginella pulvinata.. Bioorganic & medicinal chemistry letters, 20 ((8)): (2456-2460). [PMID:20335035] |
7. Janardhanan Saravanan,Shamanna Mohan,Jay Jyoti Roy. (2010-06-29) Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents.. European journal of medicinal chemistry, 45 ((9)): (4365-4369). [PMID:20579782] |
8. Xizhen Jiang,Wenlu Liu,Wei Zhang,Faqin Jiang,Zhe Gao,Hao Zhuang,Lei Fu. (2011-05-17) Synthesis and antimicrobial evaluation of new benzofuran derivatives.. European journal of medicinal chemistry, 46 ((8)): (3526-3530). [PMID:21570749] |
9. Sónia P M Ventura,Rafael L F de Barros,Tânia Sintra,Cleide M F Soares,Alvaro S Lima,João A P Coutinho. (2012-06-30) Simple screening method to identify toxic/non-toxic ionic liquids: agar diffusion test adaptation.. Ecotoxicology and environmental safety, 83 (55-62). [PMID:22742861] |
10. Ana Maria Carmona-Ribeiro. (2012-07-14) Preparation and characterization of biomimetic nanoparticles for drug delivery.. Methods in molecular biology (Clifton, N.J.), 906 (283-294). [PMID:22791441] |
11. Hala M Heneedak,Ismail Salama,Samia Mostafa,Mohamed El-Sadek. (2012-08-11) HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin.. Journal of chromatographic science, 50 ((10)): (855-861). [PMID:22879356] |
12. V M Litvinov,S Guns,P Adriaensens,B J R Scholtens,M P Quaedflieg,R Carleer,G Van den Mooter. (2012-08-22) Solid state solubility of miconazole in poly[(ethylene glycol)-g-vinyl alcohol] using hot-melt extrusion.. Molecular pharmaceutics, 9 ((10)): (2924-2932). [PMID:22905779] |
13. Jae Yong Choi,Chul Hoon Kim,Tae Joo Jeon,Byoung Soo Kim,Chi Hoon Yi,Kwang Sun Woo,Young Beom Seo,Sang Jin Han,Kyeong Min Kim,Dae Ik Yi,Minkyung Lee,Dong Goo Kim,Jung Young Kim,Kyo Chul Lee,Tae Hyun Choi,Gwangil An,Young Hoon Ryu. (2012-08-29) Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.. Synapse (New York, N.Y.), 66 ((12)): (1015-1023). [PMID:22927318] |
14. Kristy K Michael Miller,Numan Al-Rayyan,Margarita M Ivanova,Kathleen A Mattingly,Sharon L Ripp,Carolyn M Klinge,Russell A Prough. (2012-11-06) DHEA metabolites activate estrogen receptors alpha and beta.. Steroids, 78 ((1)): (15-25). [PMID:23123738] |
15. Husein Husein El Ahmed,Guillermo Arturo Cañadas-De la Fuente,Rafael Fernández-Castillo,Emilio González-Jiménez,Jesús Cantero-Hinojosa,Marita Lardón-Fernández. (2012-12-18) [Generalized cutaneous candidiasis in newborn at term].. Biomedica : revista del Instituto Nacional de Salud, 32 ((2)): (170-173). [PMID:23242288] |
16. Narendra Chopde,Amol Pharande,Mayur N Khade,Yogesh R Khadtare,Sanket S Shah,Abhishek Apratim. (2012-12-20) In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.. The journal of contemporary dental practice, 13 ((5)): (695-698). [PMID:23250177] |
17. Ana M Cerdeira,Marco Mazzotti,Bruno Gander. (2013-01-08) Formulation and drying of miconazole and itraconazole nanosuspensions.. International journal of pharmaceutics, 443 ((1-2)): (209-220). [PMID:23291552] |
18. Cristiane S Alcântara,Allana F C de Macêdo,Bruno C V Gurgel,Janaina H Jorge,Karin H Neppelenbroek,Vanessa M Urban. (2013-01-19) Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin.. Journal of applied oral science : revista FOB, 20 ((6)): (607-612). [PMID:23329241] |
19. Naomi T Jessurun,Eugène P van Puijenbroek. (2013-01-25) [Drug interactions between coumarin derivatives and antimycotics: also with topical antifungal agents].. Nederlands tijdschrift voor geneeskunde, 157 ((4)): (A5317-A5317). [PMID:23343733] |
20. Hiromi Morishige,Yoko Mano,Toyoko Oguri,Nobuhiko Furuya. (2013-02-07) Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.. The Japanese journal of antibiotics, 65 ((5)): (335-347). [PMID:23383435] |
21. Nicola Austin,Brian A Darlow,William McGuire. (2013-04-02) Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.. The Cochrane database of systematic reviews, 3 ((3)): (CD003478-CD003478). [PMID:23543519] |
22. Stanislaw A Buechner. (2013-04-06) Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.. The Journal of dermatological treatment, 25 ((3)): (226-231). [PMID:23557492] |
23. André Luiz Rossetto,Rosana Cé Bella Cruz,Vidal Haddad Junior. (2013-04-09) Double-blind study with topical Isoconazole and Terbinafine for the treatment of one patient with bilateral Tinea nigra plantaris and suggestions for new differential diagnosis.. Revista do Instituto de Medicina Tropical de Sao Paulo, 55 ((2)): (125-128). [PMID:23563768] |
24. Stefano Veraldi. (2013-04-19) The benefits of combination therapy in dermatomycoses.. Mycoses, 56 Suppl 1 (1-2). [PMID:23574018] |
25. Stefano Veraldi. (2013-04-19) Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids.. Mycoses, 56 Suppl 1 (3-15). [PMID:23574019] |
26. Viktor A Czaika,Jan Siebenbrock,Frank Czekalla,Torsten Zuberbier,Martin A Sieber. (2013-04-19) Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate.. Mycoses, 56 Suppl 1 (16-22). [PMID:23574020] |
27. Markus Friedrich. (2013-04-19) Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.. Mycoses, 56 Suppl 1 (23-25). [PMID:23574021] |
28. Viktor A Czaika. (2013-04-19) Misdiagnosed zoophile tinea faciei and tinea corporis effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.. Mycoses, 56 Suppl 1 (26-29). [PMID:23574022] |
29. Viktor A Czaika. (2013-04-19) Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy.. Mycoses, 56 Suppl 1 (30-32). [PMID:23574023] |
30. Viktor Alexander Czaika,Phi-Anh Lam. (2013-04-19) Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection.. Mycoses, 56 Suppl 1 (33-37). [PMID:23574024] |
31. Malagoli Piergiorgio. (2013-04-19) Effective treatment of erythrasma-associated inflammation and pruritus with isoconazole nitrate and diflucortolone valerate combination therapy.. Mycoses, 56 Suppl 1 (38-40). [PMID:23574025] |
32. Stefano Veraldi. (2013-04-19) Rapid relief of intertrigo-associated pruritus due to Candida albicans with isoconazole nitrate and diflucortolone valerate combination therapy.. Mycoses, 56 Suppl 1 (41-43). [PMID:23574026] |
33. Edward A Pankey,Andrea Zsombok,George F Lasker,Philip J Kadowitz. (2013-11-05) Analysis of responses to the TRPV4 agonist GSK1016790A in the pulmonary vascular bed of the intact-chest rat.. American journal of physiology. Heart and circulatory physiology, 306 ((1)): (H33-H40). [PMID:24186096] |
34. Bart Pauwels,Charlotte Boydens,Kelly Decaluwé,Johan Van de Voorde. (2014-05-21) NO-donating oximes relax corpora cavernosa through mechanisms other than those involved in arterial relaxation.. The journal of sexual medicine, 11 ((7)): (1664-1674). [PMID:24842569] |
35. S Gebremedhin,B Dorocka-Bobkowska,M Prylinski,K Konopka,N Duzgunes. (2014-09-03) Miconazole activity against Candida biofilms developed on acrylic discs.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 65 ((4)): (593-600). [PMID:25179092] |
36. Yi-Ling Hsieh,Jeremy M Merritt,Weili Yu,Lynne S Taylor. (2015-04-16) Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.. Pharmaceutical research, 32 ((9)): (3110-3118). [PMID:25874534] |
37. Takafumi Tomida,Hayao Okamura,Masahiro Satsukawa,Tsuyoshi Yokoi,Yoshihiro Konno. (2015-05-03) Multiparametric assay using HepaRG cells for predicting drug-induced liver injury.. Toxicology letters, 236 ((1)): (16-24). [PMID:25934330] |
38. Björn Neumann,Roey Baror,Chao Zhao,Michael Segel,Sabine Dietmann,Khalil S Rawji,Sarah Foerster,Crystal R McClain,Kevin Chalut,Peter van Wijngaarden,Robin J M Franklin. (2019-10-05) Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells.. Cell stem cell, 25 ((4)): (473-485). [PMID:31585093] |
39. Wei Zhang,Wenlu Liu,Xizhen Jiang,Faqin Jiang,Hao Zhuang,Lei Fu. (2011-06-07) Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.. European journal of medicinal chemistry, 46 ((9)): (3639-3650). [PMID:21641699] |
40. Jun-Ting Fan,Bin Kuang,Guang-Zhi Zeng,Si-Meng Zhao,Chang-Jiu Ji,Yu-Mei Zhang,Ning-Hua Tan. (2011-10-07) Biologically active arborinane-type triterpenoids and anthraquinones from Rubia yunnanensis.. Journal of natural products, 74 ((10)): (2069-2080). [PMID:21973054] |
41. Tarek A Ahmed,Khalid M El-Say,Maged F Mahmoud,Ahmed M Samy,Alia A Badawi. (2012-05-16) Miconazole nitrate oral disintegrating tablets: in vivo performance and stability study.. AAPS PharmSciTech, 13 ((3)): (760-771). [PMID:22585373] |
42. Reginaldo G Lima-Neto,Nery N M Cavalcante,Rajendra M Srivastava,Francisco J B Mendonça Junior,Almir G Wanderley,Rejane P Neves,Janaína V dos Anjos. (2012-05-18) Synthesis of 1,2,3-triazole derivatives and in vitro antifungal evaluation on Candida strains.. Molecules (Basel, Switzerland), 17 ((5)): (5882-5892). [PMID:22592091] |
43. Ahmet Uysal,Cüneyt Eftal Taner,Semih Mun,Söhret Aydemir. (2012-05-25) Prevention of infectious morbidity after elective abdominal hysterectomy.. Archives of gynecology and obstetrics, 286 ((4)): (959-963). [PMID:22622851] |
44. Ali Reza Khosravi,Hojjatollah Shokri,Mostafa Sharifrohani,Hosseinali Ebrahimzadeh Mousavi,Zahra Moosavi. (2012-06-14) Evaluation of the antifungal activity of Zataria multiflora, Geranium herbarium, and Eucalyptus camaldolensis essential oils on Saprolegnia parasitica-infected rainbow trout (Oncorhynchus mykiss) eggs.. Foodborne pathogens and disease, 9 ((7)): (674-679). [PMID:22690761] |
45. Byong Hoon Yoo,Sunshine Daddario Axlund,Peter Kabos,Brian G Reid,Jerome Schaack,Carol A Sartorius,Daniel V LaBarbera. (2012-07-04) A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.. Journal of biomolecular screening, 17 ((9)): (1211-1220). [PMID:22751729] |
46. J Scott Weese,Meagan Walker,Terri Lowe. (2012-07-27) In vitro miconazole susceptibility of meticillin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus.. Veterinary dermatology, 23 ((5)): (400-e74-400-e74). [PMID:22830415] |
47. Anna B Macura,Magdalena Skóra. (2012-08-14) [Fungi isolated from the vagina and their susceptibility to antifungals].. Ginekologia polska, 83 ((6)): (433-438). [PMID:22880463] |
48. Dennis de Carvalho Ferreira,Kátia Regina Netto Dos Santos,Gesmar Volga Haddad Herdy. (2012-08-30) Oral chronic hyperplastic candidiasis associated with juvenile dermatomyositis.. Revista da Sociedade Brasileira de Medicina Tropical, 45 ((4)): (540-540). [PMID:22930057] |
49. Dong-Jun Sung,Jae-Gon Kim,Kyung Jong Won,Bokyung Kim,Ho Chul Shin,Jae-Yong Park,Young Min Bae. (2012-09-15) Blockade of K+ and Ca2+ channels by azole antifungal agents in neonatal rat ventricular myocytes.. Biological & pharmaceutical bulletin, 35 ((9)): (1469-1475). [PMID:22975497] |
50. Stefano Veraldi,Maria Chiara Persico,Rossana Schianchi. (2012-11-09) Isoconazole nitrate vs isoconazole nitrate and diflucortolone valerate in the treatment of tinea inguinalis: results of a multicenter retrospective study.. Journal of drugs in dermatology : JDD, 11 ((11)): (e70-e73). [PMID:23135097] |
51. Tomonori Takami,Yue Fang,Xin Zhou,Wurentuya Jaiseng,Yan Ma,Takayoshi Kuno. (2012-11-13) A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast.. PloS one, 7 ((11)): (e49004-e49004). [PMID:23145048] |
52. Peter Belenky,Diogo Camacho,James J Collins. (2013-02-19) Fungicidal drugs induce a common oxidative-damage cellular death pathway.. Cell reports, 3 ((2)): (350-358). [PMID:23416050] |
53. Charlotte Nirma,Véronique Eparvier,Didier Stien. (2013-05-01) Antifungal agents from Pseudallescheria boydii SNB-CN73 isolated from a Nasutitermes sp. termite.. Journal of natural products, 76 ((5)): (988-991). [PMID:23627396] |
54. S M Clark,A Loeffler,R Bond. (2015-03-10) Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.. The Journal of antimicrobial chemotherapy, 70 ((7)): (2048-2052). [PMID:25749003] |